417 related articles for article (PubMed ID: 32273638)
1. A comparison of the features of fluorine-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) between IgG4-related disease with bilateral hilar lymphadenopathy and sarcoidosis.
Ozawa Y; Yamamoto H; Yasuo M; Komatsu M; Ushiki A; Hamano H; Uehara T; Kawakami S; Fujita A; Fujinaga Y; Oguchi K; Kawa S; Hanaoka M
Nagoya J Med Sci; 2020 Feb; 82(1):101-111. PubMed ID: 32273638
[TBL] [Abstract][Full Text] [Related]
2. The utility of FDG-PET/CT and other imaging techniques in the evaluation of IgG4-related disease.
Takahashi H; Yamashita H; Morooka M; Kubota K; Takahashi Y; Kaneko H; Kano T; Mimori A
Joint Bone Spine; 2014 Jul; 81(4):331-6. PubMed ID: 24568886
[TBL] [Abstract][Full Text] [Related]
3. (18)F-FDG and (18)F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes.
Rayamajhi SJ; Mittal BR; Maturu VN; Agarwal R; Bal A; Dey P; Shukla J; Gupta D
Ann Nucl Med; 2016 Apr; 30(3):207-16. PubMed ID: 26661845
[TBL] [Abstract][Full Text] [Related]
4. FDG PET for esophageal cancer complicated by sarcoidosis mimicking mediastinal and hilar lymph node metastases: two case reports.
Takanami K; Kaneta T; Yamada T; Kinomura S; Yamada S; Fukuda H; Takahashi S
Clin Nucl Med; 2008 Apr; 33(4):258-61. PubMed ID: 18356663
[TBL] [Abstract][Full Text] [Related]
5. Lymph node standardized uptake values at pre-treatment
Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW
Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776
[TBL] [Abstract][Full Text] [Related]
6. Bilateral orbital involvement of IgG4-related disease detected on 18F-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography: A Clinical Case Report.
Dong P; Wang L; Li L
Medicine (Baltimore); 2019 Nov; 98(47):e18138. PubMed ID: 31764855
[TBL] [Abstract][Full Text] [Related]
7. Recurrent Immunoglobulin G4-Related Disease Shown on 18F-FDG and 68Ga-FAPI PET/CT.
Pan Q; Luo Y; Zhang W
Clin Nucl Med; 2020 Apr; 45(4):312-313. PubMed ID: 31977476
[TBL] [Abstract][Full Text] [Related]
8. Imaging findings of primary immunoglobulin G4-related cervical lymphadenopathy.
Kawaguchi M; Kato H; Kito Y; Mizuta K; Aoki M; Kato K; Goshima S; Matsuo M
Neuroradiology; 2017 Nov; 59(11):1111-1119. PubMed ID: 28918513
[TBL] [Abstract][Full Text] [Related]
9. Utility of FDG PET/CT for Differential Diagnosis of Patients Clinically Suspected of IgG4-Related Disease.
Lee J; Hyun SH; Kim S; Kim DK; Lee JK; Moon SH; Cho YS; Choe YS; Kim BT; Lee KH
Clin Nucl Med; 2016 May; 41(5):e237-43. PubMed ID: 26914555
[TBL] [Abstract][Full Text] [Related]
10. Role of F-18 FDG PET/CT in assessing IgG4-related disease with inflammation of head and neck glands.
Tokue A; Higuchi T; Arisaka Y; Nakajima T; Tokue H; Tsushima Y
Ann Nucl Med; 2015 Jul; 29(6):499-505. PubMed ID: 25877159
[TBL] [Abstract][Full Text] [Related]
11. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
Dweck MR; Abgral R; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Palmisano A; Miller MA; Lala A; Chang HL; Sanz J; Contreras J; Narula J; Fuster V; Padilla M; Fayad ZA; Kovacic JC
JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients.
Kaira K; Oriuchi N; Otani Y; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Endo K; Mori M
Chest; 2007 Apr; 131(4):1019-27. PubMed ID: 17426205
[TBL] [Abstract][Full Text] [Related]
13. Abnormal [
Nagahata K; Kanda M; Kamekura R; Sugawara M; Yama N; Suzuki C; Takano K; Hatakenaka M; Takahashi H
Ann Nucl Med; 2022 Feb; 36(2):200-207. PubMed ID: 34748155
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of
Takano K; Yajima R; Kamekura R; Yamamoto M; Takahashi H; Yama N; Hatakenaka M; Himi T
Laryngoscope; 2018 May; 128(5):1120-1125. PubMed ID: 28988418
[TBL] [Abstract][Full Text] [Related]
15. Vascular/perivascular inflammation in IgG4-related disease.
Imai S; Tahara N; Igata S; Tahara A; Bekki M; Sugiyama Y; Maeda-Ogata S; Honda A; Otsuka H; Ushijima T; Okabe Y; Kaida H; Abe T; Tanaka H; Fukumoto Y; Tayama E
J Nucl Cardiol; 2022 Dec; 29(6):2920-2933. PubMed ID: 34704218
[TBL] [Abstract][Full Text] [Related]
16. Semiquantitative
An SY; Sun BJ
BMC Cardiovasc Disord; 2024 Feb; 24(1):122. PubMed ID: 38389040
[TBL] [Abstract][Full Text] [Related]
17. Clinical value of
Bai Z; Zhou T; Yu Z; Chen Y; Dong L
Ann Nucl Med; 2022 Jul; 36(7):651-660. PubMed ID: 35604531
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of diffuse lymphadenopathy via various quantitative PET/CT parameters.
Silov G; Çankaya E; Karaçavuş S
Hell J Nucl Med; 2023; 26(1):47-56. PubMed ID: 37031422
[TBL] [Abstract][Full Text] [Related]
19. Muscular sarcoidosis detected by F-18 FDG PET/CT in a hypercalcemic patient.
Han EJ; Jang YS; Lee IS; Lee JM; Kang S; Kim HS
J Korean Med Sci; 2013 Sep; 28(9):1399-402. PubMed ID: 24015050
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast Activation Protein-Targeted PET/CT with
Luo Y; Pan Q; Yang H; Peng L; Zhang W; Li F
J Nucl Med; 2021 Feb; 62(2):266-271. PubMed ID: 32513902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]